Related Experiment Video
Updated: May 5, 2026

An Experimental Paradigm for the Prediction of Post-Operative Pain PPOP
Published on: January 28, 2010
The morphine-prostigmin provocative test--is it useful for making clinical decisions?
The morphine-Prostigmin test is unreliable for diagnosing sphincter of Oddi disease. It frequently yields false positives in healthy individuals and shows inconsistent results, questioning its clinical utility.
Area of Science:
- Gastroenterology
- Diagnostic Medicine
Background:
- The morphine-Prostigmin test is a diagnostic tool for sphincter of Oddi dysfunction.
- Positive results, including enzyme elevation or pain reproduction, have led to surgical intervention (sphincteroplasty).
- Limited data exist on test reproducibility and responses in control populations.
Purpose of the Study:
- To evaluate the specificity and reproducibility of the morphine-Prostigmin test.
- To assess the test's response in healthy volunteers and patients with functional gastrointestinal disorders.
Main Methods:
- The morphine-Prostigmin test was administered to 10 healthy volunteers, 5 irritable bowel syndrome patients, and 4 chronic abdominal pain patients.
- Amylase, lipase levels, and symptom reproduction were monitored.
- Test reproducibility was assessed by repeat testing in some patients.
Main Results:
- 60% of healthy controls and IBS patients exhibited elevated amylase/lipase levels.
- 40% of IBS patients reported pain reproduction after the test.
- Two patients with chronic abdominal pain showed inconsistent results upon repeat testing.
Conclusions:
- The morphine-Prostigmin test lacks specificity for sphincter of Oddi disease.
- Enzyme elevation and pain reproduction are not definitive indicators.
- The test's results can vary between individuals and on different days for the same patient, limiting its clinical decision-making value.
More Related Videos
07:23Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
Published on: July 29, 2014
09:38Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery
Published on: April 14, 2016
Related Concept Videos
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Analgesia and Pain Management
Opioid Analgesics: Morphine and Other Natural Cogeners
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions